Idiopathic Generalized Epilepsy
📧 Sign up to get email alerts when something new happens for Idiopathic Generalized Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Update: Cenobamate Open-Label Extension Study for YKP3089C025 [Phase 3]
Open-label extension study for cenobamate (YKP3089) in patients with primary generalized tonic-clonic seizures associated with idiopathic ge…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Blinking and Yawning in Epilepsy: The Role of Dopamine [NA]
A completed clinical trial examining blinking and yawning in Idiopathic Generalized Epilepsy and the involvement of dopamine.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Cenobamate Open-Label Extension Study for YKP3089C025 [Phase 3]
Open-label extension study of cenobamate (YKP3089) for primary generalized tonic-clonic seizures in idiopathic generalized epilepsy, current…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Idiopathic Generalized Epilepsy Syndromes
This entry notes that a clinical trial focused on idiopathic generalized epilepsy syndromes is currently recruiting.
-
FDA approval · 2025-07-11FDA Approved: PERAMPANEL — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original ANDA for PERAMPANEL from Novadoz Pharmaceuticals LLC, making a generic version of perampanel available. This suppo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: RNS System NAUTILUS Study [Phase 3]
Update on the RNS System NAUTILUS Phase 3 trial. The study is currently active and not recruiting.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Human Epilepsy Project 3
Clinical trial update for the Human Epilepsy Project 3 (NCT05374928) indicates the study in Idiopathic Generalized Epilepsy is currently act…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Study of Attentional Disorders in Patients Suffering From Idiopathic Generalized Epilepsy.
A clinical trial studying attentional disorders in people with Idiopathic Generalized Epilepsy has been terminated.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Idiopathic Generalized Epilepsy Cognitive and Emotional Profile
A recruiting clinical trial is studying cognitive and emotional profiles in idiopathic generalized epilepsy, sponsored by IRCCS National Neu…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy
This update reports the completion of a clinical trial comparing levetiracetam to valproate for idiopathic generalized epilepsy.
-
FDA approval · 2022-03-28FDA Approved: LEVETIRACETAM — Original Application (Solco Healthcare US, LLC)
FDA approves Solco Healthcare US, LLC's generic levetiracetam through an Original Application (ANDA). The approval covers the same epilepsy …
-
FDA approval · 2021-06-11FDA Approved: LEVETIRACETAM — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved the original application (ANDA) for LEVETIRACETAM by ScieGen Pharmaceuticals, authorizing the generic product.
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Periodic Limb Movement and Genetic Generalized Epilepsy
This completed clinical trial sponsored by the University of Alexandria studied periodic limb movement in idiopathic generalized epilepsy.
-
FDA approval · 2015-12-14FDA Approved: LEVETIRACETAM — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Levetiracetam from Prasco Laboratories, resulting in updated labeling for this antiepileptic…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures [Phase 3]
Phase 3 trial evaluating safety and efficacy of levetiracetam in idiopathic generalized epilepsy with primary generalized tonic-clonic seizu…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy [Phase 3]
A Phase 3 study evaluating adjunctive zonisamide for myoclonic seizures in idiopathic generalized epilepsy was terminated; results were post…
-
FDA approval · 2012-04-11FDA Approved: LEVETIRACETAM — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved the original application for levetiracetam by Quagen Pharmaceuticals LLC, making a generic version of the antiepileptic availab…
-
FDA approval · 2010-12-14FDA Approved: LEVETIRACETAM — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approves Cranbury Pharmaceuticals' original application for a generic levetiracetam, supporting its use for partial-onset seizures, myoc…
-
FDA approval · 2010-12-13FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for levetiracetam from Aurobindo Pharma Limited, authorizing a generic Levetiracetam product under a…